⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DTIL News
Precision BioSciences, Inc. Common Stock
Form 8-K
sec.gov
DTIL
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
DTIL
Form 8-K
sec.gov
DTIL
Precision BioSciences Announces Inclusion in the Russell 2000 ® Index Expanding Market Visibility with Institutional Investors
businesswire.com
DTIL
Form 8-K
sec.gov
DTIL
Form 8-K
sec.gov
DTIL
Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026
businesswire.com
DTIL
Form 8-K
sec.gov
DTIL
Precision BioSciences to Host Investor Webcast to Discuss Late-Breaking PBGENE-HBV Data from ELIMINATE-B Trial Presented at European Association for the Study of the Liver Congress 2026
businesswire.com
DTIL
Precision BioSciences Presents New Preclinical Data Supporting the Advancement of PBGENE-DMD into Clinic at the American Society of Gene & Cell Therapy 2026 Annual Meeting
businesswire.com
DTIL